Zobrazeno 1 - 10 of 44 pro vyhledávání: '"Hiroshi Niiyama"'
1
Akademický článek
Low serum brain-derived neurotrophic factor may predict poor response to cardiac rehabilitation in patients with cardiovascular disease.
Autor: Yuya Tsukada, Yasuhiro Nishiyama, Michiya Kishimoto, Takeshi Nago, Haruhito Harada, Hiroshi Niiyama, Atsushi Katoh, Hiroo Matsuse, Hisashi Kai
Publikováno v: PLoS ONE, Vol 19, Iss 2, p e0298223 (2024)
BackgroundIt has been shown that serum brain-derived neurotrophic factor (BDNF) is associated with skeletal muscle energy metabolism and that BDNF is a predictor of mortality in heart failure patients. However, little is known about the relationship
Externí odkaz: https://doaj.org/article/23cad7603756487099a196590160eb5b
Zobrazit plný text záznamu
2
Akademický článek
New diagnostic index for sarcopenia in patients with cardiovascular diseases.
Autor: Haruhito Harada, Hisashi Kai, Rei Shibata, Hiroshi Niiyama, Yasuhiro Nishiyama, Toyoaki Murohara, Noriko Yoshida, Atsushi Katoh, Hisao Ikeda
Publikováno v: PLoS ONE, Vol 12, Iss 5, p e0178123 (2017)
Sarcopenia is an aging and disease-related syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, with the risk of frailty and poor quality of life. Sarcopenia is diagnosed by a decrease in skeletal muscle in
Externí odkaz: https://doaj.org/article/6b8230a903a24082bf0a15edb98e899c
Zobrazit plný text záznamu
3
Angiotensin II receptor blocker and statin combination therapy associated with higher skeletal muscle index in patients with cardiovascular disease: A retrospective study
Autor: Hiroshi Niiyama, Haruhito Harada, Yasuhiro Nishiyama, Hisashi Kai, Atsushi Katoh
Publikováno v: Journal of Clinical Pharmacy and Therapeutics. 47:89-96
WHAT IS KNOWN AND OBJECTIVE Reduction in skeletal muscle mass is the most important component in diagnosing sarcopenia. Ageing and chronic heart failure due to cardiovascular diseases (CVDs) accelerate the reduction of skeletal muscles. However, ther
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961e91bb43ae61c978b5e3080b5cfc71
https://doi.org/10.1111/jcpt.13540
Zobrazit plný text záznamu
4
Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies
Autor: Takanobu Maeda, Mamiko Kai, Hisashi Kai, Motoki Sasaki, Hiroshi Niiyama, Atsushi Katoh, Norihito Okina
Publikováno v: Hypertension Research
Angiotensin-converting enzyme 2 (ACE2) protects against organ damage in hypertension and cardiovascular diseases by counter regulating the renin-angiotensin system (RAS). ACE2 is also the receptor for severe acute respiratory syndrome coronavirus 2 (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8e4ba46598c0e1dcdcc09018243604
https://doi.org/10.1038/s41440-021-00641-1
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje